Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Record History shows the latest version updated to Revision: v3.5.4, replacing the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-16T09:17:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s software/interface revision indicator updates from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a site/version deployment rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T22:16:03.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:03.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    New revision added to the record history: v3.5.0 appears, indicating updates since the previous revision (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-19T21:22:10.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    A new revision (v3.4.2) was added to the Record History and the previous revision (v3.4.1) removed, reflecting a minor administrative update; this does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:21:58.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.